Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$474,406
-$58,405 QoQ
Shares Held
3,755
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,396
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Waterloo Capital, L.P. holds $23,385,515 across 8 Drug Manufacturers - General names. GILD ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,785 | $6,294,646 | |
| 2 | ABBV |
AbbVie Inc.
|
23,335 | $5,872,019 | |
| 3 | LLY |
ELI LILLY & Co
|
4,584 | $5,498,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,308 | $3,509,078 | |
| 5 | PFE |
Pfizer Inc
|
28,858 | $694,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,856 | $567,902 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,755 | $474,406 | |
| 8 | AMGN |
Amgen Inc
|
1,310 | $474,377 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,406 | 3,755 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $532,811 | 3,823 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $614,436 | 5,006 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $390,609 | 3,519 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $351,901 | 3,174 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $266,791 | 2,381 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||